New Generation Planova™ S20N
Demonstrates Robust Performance
for Multi-Specific Antibodies
Presenter:
![NickRandall](https://bpi.bioprocessintl.com/hs-fs/hubfs/3-1-2023-Asahi-ATE-Waller-HS-Cropped.png?width=147&height=221&name=3-1-2023-Asahi-ATE-Waller-HS-Cropped.png)
Jessica Waller, PhD
Principal Scientist Biologics Development,
Bristol Myers Squibb
Jessica received her PhD in physiology and neurobiology from the University of Connecticut and a bachelor's degree in biology from Stockton University. She has over seven years experience with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb. She continues to play key roles supporting early and late stage portfolio products serving as a downstream purification lead for bispecific assets and managing cross-functional collaborations.